Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 148, Issue 1, Pages (January 2018)

Published byVeronika Sanjaya Modified over 6 years ago

Similar presentations

Presentation on theme: "Volume 148, Issue 1, Pages (January 2018)"— Presentation transcript:

1 Volume 148, Issue 1, Pages 62-67 (January 2018)
Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer  Yong Jae Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim  Gynecologic Oncology  Volume 148, Issue 1, Pages (January 2018) DOI: /j.ygyno Copyright © Terms and Conditions

2 Fig. 1 Flow diagram of the study population. NAC, neoadjuvant chemotherapy. Gynecologic Oncology  , 62-67DOI: ( /j.ygyno ) Copyright © Terms and Conditions

3 Fig. 2 Definitions of the time intervals between neoadjuvant chemotherapy and adjuvant chemotherapy. NAC, neoadjuvant chemotherapy; POAC, postoperative adjuvant chemotherapy. Gynecologic Oncology  , 62-67DOI: ( /j.ygyno ) Copyright © Terms and Conditions

4 Fig. 3 Kaplan-Meier curves of progression-free survival (A) and overall survival (B) according to the time interval from the end of NAC to POAC initiation. NAC, neoadjuvant chemotherapy; POAC, postoperative adjuvant chemotherapy. Gynecologic Oncology  , 62-67DOI: ( /j.ygyno ) Copyright © Terms and Conditions

Download ppt "Volume 148, Issue 1, Pages (January 2018)"

Similar presentations

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes  Stuart E. Samuels, MD, PhD, Matthew.

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes  Stuart E. Samuels, MD, PhD, Matthew.
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.
Volume 144, Issue 1, Pages (January 2017)

Volume 144, Issue 1, Pages (January 2017)
The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
Efficacy of Polyglycolic Acid Sheet After Thoracoscopic Bullectomy for Spontaneous Pneumothorax  Seokkee Lee, MD, Seong Yong Park, MD, Mi Kyung Bae, MD,

Efficacy of Polyglycolic Acid Sheet After Thoracoscopic Bullectomy for Spontaneous Pneumothorax  Seokkee Lee, MD, Seong Yong Park, MD, Mi Kyung Bae, MD,
Sarah J. Gao, BS, Christopher D. Corso, MD, PhD, Elyn H

Sarah J. Gao, BS, Christopher D. Corso, MD, PhD, Elyn H
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)
Are patients willing to travel for better ovarian cancer care?

Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)
L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L
Volume 150, Issue 3, Pages (September 2018)

Volume 150, Issue 3, Pages (September 2018)
The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors 

The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors 
A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L

A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L
Clinical Characteristics and Prognostic Factors of Primary Pulmonary Vein Stenosis or Atresia in Children  Mi Kyoung Song, MD, Eun Jung Bae, MD, Soo In.

Clinical Characteristics and Prognostic Factors of Primary Pulmonary Vein Stenosis or Atresia in Children  Mi Kyoung Song, MD, Eun Jung Bae, MD, Soo In.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Seizure - European Journal of Epilepsy

Seizure - European Journal of Epilepsy

Similar presentations

Ads by Google